Best 1 contract

Active Definitive Contract Awarded Last action

Contract number
75F40126C00218
Awardee
Awarding agency
Obligated
$12,919,772

Award facts

Opportunity
  • FDAINTENTSOLESOURCEBEST1A Solicitation number
Contract value 32% obligated
  • $12,919,772.39 Current, with exercised options
  • $40,818,211.96 Potential, with all options
Completion date 2% complete
  • Current, with exercised options
  • Potential, with all options
Contracting staff
NAICS code
541690 Other Scientific and Technical Consulting Services
PSC
AN41 Health R&D Services; Health Care - Other; Basic Research
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Hillsborough, CA 94010, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration awarded a definitive contract to Acumen LLC (doing business as Medric) for $40.8 million on September 30, 2026, with an ultimate completion date of September 29, 2029, under the BEST 1 (Biologics Effectiveness and Safety) Initiative with no set-aside.

The contract is firm fixed price. Place of performance is Hillsborough, CA. The BEST Initiative supports post-market surveillance of biologic products, building on Acumen's existing $75 million BEST indefinite delivery contract awarded September 27, 2024. Acumen operates as a healthcare data analytics and program evaluation firm across multiple federal health agencies, with the majority of its $18.09 billion combined potential value concentrated in CMS indefinite delivery vehicles serving data analytics, research, and policy development roles. The vendor maintains a stable federal workforce of 164–169 FTEs annually across SCI-reportable contracts, with government-paid hourly rates ranging from $109.64 to $177.71 per hour at the 10th and 90th percentiles respectively, reflecting a mix of research analysts, data scientists, and technical management roles. Acumen engages subcontractors for approximately 45 percent of contractor hours across its federal service delivery model.

Quick answers

Who was awarded contract 75F40126C00218?

75F40126C00218 was awarded to Acumen LLC by Food and Drug Administration (Department of Health and Human Services) on September 30, 2026.

How much is contract 75F40126C00218 worth?

The government has obligated $12,919,772 on 75F40126C00218. Its potential value, with all options, is $40,818,212.

Was contract 75F40126C00218 competed?

The extent of competition for 75F40126C00218 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award